Literature DB >> 11389357

Acute myocarditis.

A S Batra1, A B Lewis.   

Abstract

Myocarditis is defined as inflammation of the myocardium accompanied by myocellular necrosis. Acute myocarditis must be considered in patients who present with recent onset of cardiac failure or arrhythmia. Often there is a history of an antecedent flu-like illness. Fulminant myocarditis is a distinct entity characterized by sudden onset of severe congestive heart failure or cardiogenic shock, usually following a flu-like illness. Giant cell myocarditis is a rare, frequently fatal disorder of unknown origin characterized by presence of giant cell inflammatory infiltrate in the myocardium. In recent years we have made good progress in understanding the causes, pathogenesis, natural history, diagnosis, and treatment of myocarditis. However, our knowledge is still far from complete. New information that extends our understanding of myocarditis is being reported constantly. This review summarizes recent advances in myocarditis, with an emphasis on the literature during the last year.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11389357     DOI: 10.1097/00008480-200106000-00004

Source DB:  PubMed          Journal:  Curr Opin Pediatr        ISSN: 1040-8703            Impact factor:   2.856


  15 in total

1.  Eosinophilic myocarditis presenting with pediatric myocardial infarction.

Authors:  C L Lindblade; E C Kirkpatrick; E S Ebenroth
Journal:  Pediatr Cardiol       Date:  2006 Jan-Feb       Impact factor: 1.655

2.  Children with fulminant myocarditis rescued with extracorporeal membrane oxygenation.

Authors:  E-T Wu; S-C Huang; Y-S Chen; J-K Wang; M-H Wu; W-J Ko
Journal:  Heart       Date:  2006-09       Impact factor: 5.994

3.  NT-proBNP as a marker for persistent cardiac disease in children with history of dilated cardiomyopathy and myocarditis.

Authors:  N Nasser; Z Perles; A J J T Rein; A Nir
Journal:  Pediatr Cardiol       Date:  2006 Jan-Feb       Impact factor: 1.655

Review 4.  Current treatment options in (peri)myocarditis and inflammatory cardiomyopathy.

Authors:  B Maisch; S Pankuweit
Journal:  Herz       Date:  2012-09       Impact factor: 1.443

5.  Fulminant pH1N1-09 influenza-associated myocarditis in pediatric patients.

Authors:  Erica R Gross; Jeffrey W Gander; Ari Reichstein; Robert A Cowles; Charles J H Stolar; William Middlesworth
Journal:  Pediatr Crit Care Med       Date:  2011-03       Impact factor: 3.624

Review 6.  Standard and etiology-directed evidence-based therapies in myocarditis: state of the art and future perspectives.

Authors:  Bernhard Maisch; Sabine Pankuweit
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

7.  Pediatric patients hospitalized with myocarditis: a multi-institutional analysis.

Authors:  Darren Klugman; John T Berger; Craig A Sable; Jianping He; Sachin G Khandelwal; Anthony D Slonim
Journal:  Pediatr Cardiol       Date:  2010-02       Impact factor: 1.655

8.  Sudden death related myocarditis: a study of 56 cases.

Authors:  Indira D Kitulwatte; Patrick J H Kim; Michael S Pollanen
Journal:  Forensic Sci Med Pathol       Date:  2009-11-29       Impact factor: 2.007

Review 9.  Immunosuppressive therapy in acute myocarditis: an 18 year systematic review.

Authors:  C P P Hia; W C L Yip; B C Tai; S C Quek
Journal:  Arch Dis Child       Date:  2004-06       Impact factor: 3.791

Review 10.  Tea polyphenols regulate key mediators on inflammatory cardiovascular diseases.

Authors:  Jun-ichi Suzuki; Mitsuaki Isobe; Ryuichi Morishita; Ryozo Nagai
Journal:  Mediators Inflamm       Date:  2009-07-19       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.